BenjaminRHanischMD

Pediatric Infectious Disease • Washington, DC

Pediatric Infections Associated with Transplant/Immunocompromised States

Physician

Join to view full profile

Dr. Hanisch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hanisch's full profile

Already have an account?

Office
111 Michigan Ave NW
Washington, DC 20010
Phone+1 202-476-5000

Summary

Dr. Benjamin Hanisch is a pediatric infectious disease specialist in Washington, DC and is affiliated with Children's National Health System. He received his medical degree from Penn State College of Medicine. He specializes in pediatric infections associated with transplant/immunocompromised states.

Education & Training

University of MinnesotaFellowship, Pediatric Infectious Diseases, 2011 - 2014
University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 2008 - 2011
Pennsylvania State University College of MedicineClass of 2008

Certifications & Licensure

DC State Medical License 2014 - 2026
MD State Medical License 2024 - 2026
VA State Medical License 2024 - 2026
MN State Medical License 2014 - 2017
WI State Medical License 2010 - 2011
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Infectious Diseases

Publications & Presentations

PubMed

Toxoplasmosis Prophylaxis Practices: A Survey of International Pediatric Solid Organ Transplantation Centers.
Benjamin R Hanisch, Monica I Ardura, Inci Yildirim, Mignon McCulloch, Marian G Michaels
Pediatric Transplantation. 2025-05-01
Positive Pre-Transplant Respiratory Viral PCR is Associated With Increased Day 100 Transplant-Related Mortality in Pediatric HSCT Recipients.
Jane Trainor, Benjamin Hanisch, Kelly Lyons Snelling, Rachel Dori, John Robert Barber
Pediatric Blood & Cancer. 2025-03-22
1 citations
Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial.
Heidi Segers, Jaime G Deville, William J Muller, Angela Manzanares, Amit Desai
Antimicrobial Agents and Chemotherapy. 2024-12-05

Press Mentions

Children’s National Hospital Case Report Sounds the Alarm for Antibiotic ResistanceAugust 5th, 2020